drugset / Trial / NCT00637117

Intratumoral Dendritic Cell Vaccination Combined With Local Radiotherapy in Patients With Recurrent Lymphoma.

NCT00637117

Phase 1/2 Withdrawn Baylor Research Institute
NaSingle-groupOpen-labelTreatment

Summary

The purpose of the study is to gather data on feasibility and on immune and clinical efficacy of intratumoral dendritic cell (DC) vaccination in combination with local radiotherapy in patients with recurrent lymphoma

Timeline

Start
2008-07
Primary completion
2010-03
Completion
2010-03

Drugs

EvaluationDrugModalityDoseRoute
Subject autologous dendritic cells Cell therapy 0.5 ml Other

Indications